# Biomarker Analysis of Central Nervous System Tumors

> **NCT02692898** · — · TERMINATED · sponsor: **National Cancer Institute (NCI)** · enrollment: 12 (actual)

## Conditions studied

- Central Nervous System Neoplasms
- Primary Brain Neoplasms
- Neoplasms, Brain
- Cancer of the Brain
- Brain Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02692898
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2016-02-25
- **Primary completion:** 2019-11-15
- **Final completion:** 2019-11-15
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2019-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02692898

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02692898, "Biomarker Analysis of Central Nervous System Tumors". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02692898. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*